Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 90444

1 recalled-product record grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
June 16, 2022
Product types
Drug
Classifications
Class II
Statuses
Terminated
Recalling firm wording
Macleods Pharma Usa Inc

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Eszopiclone Tablets, USP 1 mg, packaged in 30-count bottles, Rx Only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd., Baddi, Himachal Pradesh, INDIA, NDC 33342-299-07

D-1174-2022
Recall number
D-1174-2022
Initiated
June 16, 2022
Classification
Class II
Status
Terminated
Recalling firm
Macleods Pharma Usa Inc
Quantity
168690 Tablets

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Shortfill: customer complaints of one to three tablets were reported missing from 30 count bottles.

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Shortfill: customer complaints of one to three tablets were reported missing from 30 count bottles.

Code information

Lot #: BEK2009A Exp: 11/2023

Distribution pattern

Distributed Nationwide and Puerto Rico.